Cargando…
Effects of the Antimicrobial Peptide LL-37 and Innate Effector Mechanisms in Colistin-Resistant Klebsiella pneumoniae With mgrB Insertions
BACKGROUND: Colistin is a polypeptide antibiotic drug that targets lipopolysaccharides in the outer membrane of Gram-negative bacteria. Inactivation of the mgrB-gene is a common mechanism behind colistin-resistance in Klebsiella pneumoniae (Kpn). Since colistin is a cyclic polypeptide, it may exhibi...
Autores principales: | Al-Farsi, Hissa M., Al-Adwani, Salma, Ahmed, Sultan, Vogt, Carmen, Ambikan, Anoop T., Leber, Anna, Al-Jardani, Amina, Al-Azri, Saleh, Al-Muharmi, Zakariya, Toprak, Muhammet S., Giske, Christian G., Bergman, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6870453/ https://www.ncbi.nlm.nih.gov/pubmed/31803163 http://dx.doi.org/10.3389/fmicb.2019.02632 |
Ejemplares similares
-
MgrB Mutations and Altered Cell Permeability in Colistin Resistance in Klebsiella pneumoniae
por: Yap, Polly Soo-Xi, et al.
Publicado: (2022) -
MgrB Alterations Mediate Colistin Resistance in Klebsiella pneumoniae Isolates from Iran
por: Haeili, Mehri, et al.
Publicado: (2017) -
Absence of mgrB Alleviates Negative Growth Effects of Colistin Resistance in Enterobacter cloacae
por: Wozniak, Jessie E., et al.
Publicado: (2020) -
MgrB-Dependent Colistin Resistance in Klebsiella pneumoniae Is Associated with an Increase in Host-to-Host Transmission
por: Bray, Andrew S., et al.
Publicado: (2022) -
Clinical and molecular characteristics of carbapenem non-susceptible Escherichia coli: A nationwide survey from Oman
por: Al-Farsi, Hissa M., et al.
Publicado: (2020)